Roman Chamomile - Chamaemelum Nobile

Date

March 27, 2026

Proper name(s), Common name(s), Source information

References: Proper name: USDA 2024; Common names: USDA 2024; Gardner and McGuffin 2013; Source information: Wichtl 2004; Bradley 1992.

Route of Administration

Oral (Wichtl 2004; Bradley 1992)

Dosage Form(s)

This monograph excludes foods or food-like dosage forms as indicated in the Compendium of Monographs Guidance Document.

Acceptable dosage forms for oral use are indicated in the dosage form drop-down list of the web-based Product Licence Application form for Compendial applications.

Use(s) or Purpose(s)

(Traditionally) used in Herbal Medicine to help relieve mild digestive upset (such as dyspepsia, nausea and flatulence) (Wichtl 2004; Mills and Bone 2000; Bradley 1992; BHP 1983; Felter 1983; Ellingwood 1983).

Notes

• For multi-ingredient products:
  • To prevent the product from being represented as a "traditional medicine", any indicated traditional use claim must refer to the specific medicinal ingredient(s) and recognized traditional system of medicine from which the claim originates when 1) both traditional and modern claims are present or 2) when claims originate from multiple systems of traditional medicine (e.g., Roman chamomile is traditionally used in Herbal Medicine to help relieve mild digestive upset).
  • When ALL of the medicinal ingredients (MIs) in the product are used within the SAME identified system of traditional medicine AND the product makes ONLY traditional claims, listing of MIs in the traditional claim(s) is not required.

Dose(s)

Subpopulation(s)

Adults 18 years and older

Quantity(ies)

Methods of preparation: Dry, Powdered, Non-Standardized Extracts (Dry extract*, Tincture, Fluid extract, Decoction, Decoction concentrate, Infusion, Infusion concentrate)

1.8 - 12 grams of dried flower, per day (Wichtl 2004; Bradley 1992; BHP 1983)

Note*: Solvents allowed for the method of preparation "Non-Standardized Extracts (Dry extract)" as part of this monograph are ethanol and/or water only.

Direction(s) for use

No statement required.

Duration(s) of Use

No statement required.

Risk Information

Caution(s) and warning(s)

Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

Contraindication(s)

No statement required.

Known adverse reaction(s)

Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2000; Blumenthal et al. 1998).

Non-medicinal ingredients

Must be chosen from the current Natural Health Products Ingredients Database (NHPID) and must meet the limitations outlined in the database.

Storage conditions

Must be established in accordance with the requirements described in the Natural Health Products Regulations.

Specifications

• The finished product specifications must be established in accordance with the requirements described in the Natural and Non-prescription Health Products Directorate (NNHPD) Quality of Natural Health Products Guide.
• The medicinal ingredient must comply with the requirements outlined in the NHPID.

EXAMPLE OF PRODUCT FACTS:

Consult the Guidance Document, Labelling of Natural Health Products for more details.

References Cited

• BHP 1983: British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 1983.
• Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS, editors. Herbal Medicine: Complete Commission E Monographs. Boston (MA): Integrative Medicine Communications; 1998.
• Bradley PR, editor. British Herbal Compendium, Volume 1. Bournemouth (GB): British Herbal Medicine Association; 1992.
• Brinker F. Herb Contraindications and Drug Interactions, 4^th edition. Sandy (OR): Eclectic Medical Publications; 2010.
• Ellingwood F. The American Materia Medica, Therapeutics and Pharmacognosy. Sandy (OR): Eclectic Medical Publications; 1919.
• Felter HW. The Eclectic Materia Medica, Pharmacology and Therapeutics. Sandy (OR): Eclectic Medical Publications; 1992.
• Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2^nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
• Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
• Mills S, Bone K. 2000. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone.
• USDA 2024: United States Department of Agriculture, Agricultural Research Service (USDA ARS), Germplasm Resources Information Network (GRIN) - Global. U.S. National Plant Germplasm System. [Accessed 2024 July 25]. Available at: https://npgsweb.ars-grin.gov/gringlobal/taxon/taxonomysearch
• Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis. 3^rd edition. Stuttgart (DE): Medpharm GmbH Scientific Publishers; 2004.

References Reviewed

• Barnes J, Anderson LA, Phillipson JD. Herbal Medicines, 3^rd edition. Grayslake (IL): Pharmaceutical Press; 2007.
• Carnat A, Carnat AP, Fraisse D, Ricoux L, Lamaison JL. The aromatic and polyphenolic composition of Roman camomile tea. Fitoterapia 2004;75(1):32-38;.
• Mills S, Bone K. The Essential Guide to Herbal Safety. Amsterdam (NL): Elsevier; 2005.

Version History